Hide Board Information

Show Board Information

Generex Biotechnology Corp. GNBTQ

Board Mod: rjs9787

Asst Mods: docj

Last Post: 02/01/2025 10:22:38 AM

Board Marks: 123

Posts Today: 0

Board Views Today: 680

Generex Biotechnology Corp. (NYSE: GNBTQ) Stock Message Board

1. GNBTQ Company Profile

    

2. GNBTQ Time & Sales

    

3. GNBTQ Recent News

    

4. GNBTQ Filings

    

5. GNBTQ Financials

    

6. GNBTQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

25300	While my GNBT shares are looking great today...	DJknows	01/11/2021 2:59:13 PM
25299	Either GNBT has to go up, or NGIO valuation has (7)	SeekingAlfa	01/11/2021 2:53:51 PM
25298	Ive got 3 orders in and 3 filled. (2)	Buildit	01/11/2021 2:12:01 PM
25297	If you go to (3)	Assiduous	01/11/2021 1:59:19 PM
25296	You could see a sudden spike down if investors	docj	01/11/2021 1:51:59 PM
25295	In Florida, they make your second appointment	OrlandoJohn	01/11/2021 1:46:14 PM
25294	good luck ... I'm a little concerned about that	balleroni	01/11/2021 1:39:39 PM
25293	I am wondering who holds the highest number	rvbpk	01/11/2021 1:39:13 PM
25292	Getting mine this Friday. Moderna	OrlandoJohn	01/11/2021 1:35:44 PM
25291	Some. CDEL jumped ahead of me with their buy. I	docj	01/11/2021 1:34:42 PM
25290	wow, up 30%!	OrlandoJohn	01/11/2021 1:34:28 PM
25289	And are you working on that right now?	Buildit	01/11/2021 1:27:02 PM
25288	I have about 20k left to buy to make a very nice (2)	docj	01/11/2021 1:13:13 PM
25287	I just ate the last 8440 @ .295... no block	Buildit	01/11/2021 1:04:54 PM
25286	I'm not excited to get this vaccine (Pfizer or	balleroni	01/11/2021 12:59:15 PM
25284	CDEL is a MM who works orders on behalf of large (1)	docj	01/11/2021 12:28:42 PM
25283	From what I've seen today, this is different,	Buildit	01/11/2021 12:10:27 PM
25282	Can anyone explain what the endgame is behind the	Southbill	01/11/2021 12:07:22 PM
25281	I'm actually surprised that I don't see large	balleroni	01/11/2021 11:45:10 AM
25280	I was busy and was not paying attention to my (4)	rvbpk	01/11/2021 11:32:49 AM
25279	We really need some investors that realize the (1)	hylander	01/11/2021 10:54:27 AM
25278	37/39 Let's make sure and hold 27 though. I love (2)	docj	01/11/2021 10:12:37 AM
25277	Any guesses where points of resistance might be (2)	balleroni	01/11/2021 10:10:03 AM
25276	Happy birthday Joe Moscato. May this year be your (8)	rjs9787	01/11/2021 9:47:16 AM
25275	I like your analogy except with Generex the (1)	Wasabi	01/11/2021 9:17:35 AM
25274	So here is my take on the valuation of NGIO we (3)	Zolis_onkel	01/11/2021 1:13:01 AM
25273	When youre right youre right. For some (1)	Pokey123	01/10/2021 11:50:38 PM
25272	The percentage you own of NGIO would stay the (3)	AlbertD	01/10/2021 10:39:59 PM
25271	You can look at it like they have no value. I (1)	Pokey123	01/10/2021 10:30:18 PM
25270	Personally, I am for whatever it takes to get (1)	hylander	01/10/2021 10:26:04 PM
25269	Has it been done before? And would it really be (2)	AlbertD	01/10/2021 9:59:59 PM
25268	A reverse split on shares that have never been (1)	Pokey123	01/10/2021 9:41:55 PM
25265	True doc, but we havent been told an ipo date	tc2000chartreader	01/10/2021 6:31:51 PM
25264	Agreed, the NGIO preferred would come after the	Buildit	01/10/2021 6:27:50 PM
25263	This has always been the problem for Generex and	docj	01/10/2021 5:44:01 PM
25262	https://www.investopedia.com/ask/answers/042015/w (1)	tc2000chartreader	01/10/2021 5:38:33 PM
25261	Forgot all about the preferred shares. I would	tc2000chartreader	01/10/2021 5:35:48 PM
25260	You are comparing an unknown NGIO value to a	tc2000chartreader	01/10/2021 5:34:12 PM
25259	TC, Unfortunately, the odds are that you are (1)	Assiduous	01/10/2021 5:21:51 PM
25258	Agreed on the GNBT PPS. There has been to many	AlbertD	01/10/2021 4:53:16 PM
25257	Actually I cant imagine the market will (1)	tc2000chartreader	01/10/2021 4:19:31 PM
25256	Sinopharm/Sinovac	GMIN	01/10/2021 4:04:02 PM
25255	Another Vaccine tracker,	GMIN	01/10/2021 3:26:02 PM
25254	We can certainly hope... but when it was valued @	Buildit	01/10/2021 2:40:01 PM
25253	Actually GNBT could get up-listed to NASDAQ (1)	Assiduous	01/10/2021 2:12:42 PM
25252	Covid fact check: According to the CDC (2)	Assiduous	01/10/2021 1:51:34 PM
25251	I guess after NGIO gets listed. GNBT can sell (2)	tc2000chartreader	01/10/2021 1:37:37 PM
25250	Anyone know what happened to Creekrat? Havent	OrlandoJohn	01/10/2021 12:07:21 PM
25249	When will a listing upgrade for GNBT	OrlandoJohn	01/10/2021 12:05:32 PM
25248	Take a gander at the who we are page. Most (2)	Cody760	01/10/2021 9:23:48 AM

Newer

Older

Recent Articles

• Unlocking the Future of Personal Asset Management with Covet
• LAVA Therapeutics Explores Strategic Alternatives for Growth
• Revolutionizing Home Electrification: Schneider Electric's Latest Solution
• MicroStrategy Experiences a Stock Decline Amidst Bitcoin Drops
• Spero Therapeutics Engages at Health Care Conference in Boston
• Rembrand Unleashes AI Contest to Redefine Video Creativity
• Top Health Care Innovators Gear Up for RISE National 2025
• NeoVolta Inc. Advances Energy Storage with Major Loan Approval
• Introducing 'Docology': A Revolutionary Health Podcast
• Ocular Therapeutix Insights on Upcoming Conferences and Growth
• Edera Secures $15 Million to Elevate Cloud Security Solutions
• Dillard's, Inc. Financial Results Highlight Sales Trends
• Shoals Technologies Updates Q4 2024 Financial Performance
• Broadridge Rises to the Top for Asset Management Solutions
• Republic Business Credit Secures $1.5Million for Apparel Growth
• Powerhouse Consulting Group Partners with Ripley PR for Success
• Elanco Teams Up with Medgene to Combat Avian Influenza in Cattle
• Elanco Animal Health Releases 2024 Financial Report Insights
• Climb Bio Announces Participation in Major Investor Conferences
• Shutterstock, Inc. Reports Significant Growth in 2024 Earnings
• Plug Power Prepares for 2024 Year-End Results Announcement
• Mobilicom's SkyHopper PRO Micro Joins U.S. Defense Tech List
• Stantec Reports Record Earnings with Increased Dividend for 2025
• Fulcrum Therapeutics Reports Q4 and Year-End 2024 Milestones
• Balchem Corporation's Impact on Global Health Ingredients Market
• Aura Biosciences: Spotlight on Upcoming Investor Events
• Syndax Pharmaceuticals Set for Major Investor Conferences Soon
• Upcoming Investment Conferences Spotlight Foghorn Therapeutics
• Regenx Expands Leadership with New Board Member and Auditor
• Macerich Leaders to Speak at Upcoming Global Property Event
• Sintana Energy's Exciting Discoveries in Namibia's Orange Basin
• Adverum Biotechnologies Set to Present at Major Healthcare Event
• LGI Homes, Inc. Sees Strong Growth in 2024 Despite Challenges
• TransUnion's Upcoming Presentation at RBC Capital Markets Conference
• Dillard's, Inc. Reveals Annual Financial Insights for 2025
• ChampionX Finalizes Major Sale Agreement with LongRange Capital
• Allot Ltd. Celebrates Profitability After Strong Q4 Growth
• Harry Slatkin Unveils Dwell212: A Scented Body Care Revolution
• Huber Management Strengthens Investment Strategies with New Team
• Innovative Smart Energy Solutions Unveiled by SUNHOME
• Eli Lilly Enhances Zepbound Accessibility and Affordability
• Simplilearn Welcomes Shane Clem as New Vice President of Strategic Partnerships
• NeoVolta Advances with $300M DOE Loan Application Approval
• Exploring Future Growth and Trends of the Oyster Sauce Market
• Aurum's Bold Move in Blockchain: $12M Investment Secured
• Simplifying Defense Export Compliance with Innovative Solutions
• Brazil Potash Takes Significant Steps in Autazes Project Development
• Castellum, Inc.'s GTMR Earns Major Contract with NAWCAD
• Amesite Revolutionizes Healthcare Sales Transforming NurseMagic™
• NKT A/S Announces Upcoming Annual General Meeting Details